Lessons learned from phase 3 trials of immunotherapy for glioblastoma: Time for longitudinal sampling? is a research paper published in Neuro-Oncology (2023). On theSindex it has a DataRank of 0. It has been cited 36 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: P01 CA163205
National Cancer Institute
Grant: P01 CA236749
National Institutes of Health
Grant: R01NS110942
National Institutes of Health
Grant: 2T32CA079443